Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 11—November 2008


Antimicrobial Drug Use and Resistance in Europe

CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians. Medscape, LLC designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at; (4) view/print certificate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify the classes of antimicrobial drugs most commonly used in Europe.
  • Describe patterns of antimicrobial drug use across regions in Europe.
  • Identify the most widely used antimicrobial drugs by country in Europe.
  • List European countries that show the highest antimicrobial drug resistance proportions.
  • Describe the association between antimicrobial drug use and the emergence of resistance.

CME Editor

Anne Mather, Technical Writer-Editor, Emerging Infectious Diseases. Disclosure: Anne Mather has disclosed no relevant financial relationships.

CME Author

Désirée Lie, MD, MSEd, Clinical Professor, Family Medicine, University of California, Orange, California, USA; Director, Division of Faculty Development, UCI Medical Center, Orange. Disclosure: Désirée Lie has disclosed no relevant financial relationships.


Disclosures: Nienke van de Sande-Bruinsma, MSc, PhD; Hajo Grundmann, MD, PhD; Didier Verloo, DVM; Edine Tiemersma, PhD; Jos Monen, MSc; Herman Goossens, MD, PhD; and Matus Ferech, MSc, PhD, have disclosed no relevant financial relationships.


Article Navigation